- Conditions
- Colitis, Ulcerative
- Interventions
- LYC-30937-EC
- Drug
- Lead sponsor
- Lycera Corp.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 112 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 9
- States / cities
- Little Rock, Arkansas • Mission Hills, California • Miami, Florida + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Psoriasis
- Interventions
- Drug: LYC-30937-EC, Placebo
- Drug
- Lead sponsor
- Lycera Corp.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 7
- States / cities
- Carmel, Indiana • Andover, Massachusetts • Fridley, Minnesota + 4 more
- Conditions
- Colitis, Ulcerative
- Interventions
- LYC-30937-EC, Placebo
- Drug
- Lead sponsor
- Lycera Corp.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 26
- States / cities
- Little Rock, Arkansas • Long Beach, California • Mission Hills, California + 20 more
- Conditions
- Cancer
- Interventions
- LYC-55716
- Drug
- Lead sponsor
- Lycera Corp.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 119 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 20
- States / cities
- Huntsville, Alabama • Sacramento, California • Washington D.C., District of Columbia + 17 more
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- LYC-55716, Pembrolizumab
- Drug
- Lead sponsor
- Lycera Corp.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 4
- States / cities
- Aurora, Colorado • Ann Arbor, Michigan • Nashville, Tennessee + 1 more